Date: July 30, 2026
Regulatory Compliance Disclosure
Shareholder Voting Process Update
The Company is providing a 48-hour period from the date and time of publication of this disclosure for shareholders to submit comments, observations, or objections regarding the modifications contained in the Corrigendum to the Postal Ballot Notice.
Submission Channels
Comments may be submitted through the following email addresses:
- Company Email: investors@balpharma.com
- Scrutinizer's Email: parameshwar@vjkt.in
Voting Revision Opportunity
Members who had already cast their votes prior to the issuance of the Corrigendum have been provided an opportunity to revise or modify their votes in accordance with the procedure specified in Point No. 10 of the Corrigendum.
Remote E-Voting Schedule
The remote e-voting facility shall remain open until 5:00 PM (IST) on Saturday, August 8, 2026, in accordance with the Postal Ballot Notice read together with the Corrigendum.
Document Availability
The intimation has been made available on the company website at www.balpharma.com.